About The Study: There were significant increases in human papillomavirus (HPV) vaccine administration among commercially insured adults ages 27 to 45 after the Advisory Committee on Immunization Practices recommended patient-clinician shared decision-making for HPV vaccination for this age group in 2019. Further research is warranted to explore the decision-making process in receiving HPV vaccination and to develop effective decision aids to maximize the cancer prevention benefit in this age group.
Authors: Ryan Suk, Ph.D., M.S., of the University of Texas Health Science Center at Houston School of Public Health, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2022.4716)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.4716?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121622
About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
JAMA Health Forum